Biotech Values

[DewDiligence]

…FDA has gotten much tougher on names…that may suggest efficacy.

This policy has been in effect for a long time. For instance, Upjohn wanted to name their anti-baldness drug Regaine and the FDA made them change it to Rogaine. That was in 1988.